Morgan Stanley »

Prosomnus shares owned by Morgan Stanley

Quarter-by-quarter ownership of Prosomnus (OSA) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Prosomnus

Tip: Access up to 7 years of quarterly data

All positions including Prosomnus held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prosomnus by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $623 1.1k 0.57
2023-09-30 $1.2k 1.1k 1.05
2023-06-30 $4.9k 1.6k 3.10

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
UnitedHealth (UNH)

View all positions for Morgan Stanley

Top funds holding Prosomnus

Forbes Financial Planning
Polar Securities
Wells Fargo & Company
Vanguard Group
Littlejohn & Co
LPWM
Geode Capital Management
Tradition Wealth Management
Bridgeway Capital Management
Axxcess Wealth Management
Spears Abacus Advisors
Presidio Capital Management
BlackRock
JustInvest
HBK Sorce Advisory

View all funds holding Prosomnus